Transition-Metal-Free N9-Amidoalkylation of Purines with N,N-Dialkylamides
摘要:
A novel method for the selective N9-amidoalkylation of purines using N,N-dialkylamides as alkylation reagents via activation of sp(3) C-H bond adjacent to an amide nitrogen atom has been developed in the presence of KI and tert-butyl hydroperoxide (TBHP). This method was simple to operate and provided series of purine derivatives in moderate to excellent yield.
Synthesis and evaluation of 3′-azido-2′,3′-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus
作者:Hong-wang Zhang、Steven J. Coats、Lavanya Bondada、Franck Amblard、Mervi Detorio、Ghazia Asif、Emilie Fromentin、Sarah Solomon、Aleksandr Obikhod、Tony Whitaker、Nicolas Sluis-Cremer、John W. Mellors、Raymond F. Schinazi
DOI:10.1016/j.bmcl.2009.11.031
日期:2010.1
Based on the promising drug resistance profile and potent anti-HIV activity of β-d-3′-azido-2′,3′-dideoxyguanosine, a series of purine modified nucleosides were synthesized by a chemical transglycosylation reaction and evaluated for their antiviral activity, cytotoxicity, and intracellular metabolism. Among the synthesized compounds, several show potent and selective anti-HIV activity in primary lymphocytes
基于 β- d -3'-azido-2',3'-dideoxyguanosine具有良好的耐药性和强大的抗 HIV 活性,通过化学转糖基化反应合成了一系列嘌呤修饰的核苷,并评估了它们的抗病毒活性、细胞毒性和细胞内代谢。在合成的化合物中,有几种在原代淋巴细胞中显示出有效和选择性的抗 HIV 活性。
[EN] NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT<br/>[FR] ANALOGUES DE NUCLÉOSIDES ET DE NUCLÉOTIDES PORTANT UN CENTRE STÉRÉOGÈNE TOUT CARBONE QUATERNAIRE EN POSITION 2' ET PROCÉDÉS D'UTILISATION EN TANT QU'AGENT CARDIOPROTECTEUR
申请人:LCB PHARMA INC
公开号:WO2018049534A1
公开(公告)日:2018-03-22
Nucleoside and nucleotide analogues that can be used as cardioprotective agents are provided. The nucleosides and nucleotide analogues comprise tetrahydrofuranyl or tetrahydrothienyl moieties with quaternary stereogenic all-carbon centers at the 2' position and a phosphonate ester at the 5' position.
Chemical transformation/derivatization of O6-methyl- and O6-(hydroxyethyl)guanine for detection by GC-EC/MS
作者:Chingchen S. Chiu、Manasi. Saha、Amir. Abushamaa、Roger W. Giese
DOI:10.1021/ac00069a021
日期:1993.11.1
In this project we set out to make an important class of DNA adducts, comprising O6-alkyl and O6-(hydroxyalkyl)guanines, susceptible to sensitive detection by GC-EC/MS. While existing literature indicated that pentafluorobenzylation would be useful for the ring NH site on these compounds, how to best overcome the polarity of the exocyclic NH2 and OH groups, without losing the O6-alkyl moiety, was less clear. Working with O6-methylguanine and O6-(2'-hydroxyethyl)guanine as representative analytes, we found that the NH2 group could be converted into fluoro without loss of the O6 substituent. For the OH group, a comparison of several derivatives (OR') led to R' = tert-butyl as the best choice at this stage. The latter work, especially via NMR, also allowed exact structural assignments to be made for the N7 and N9 pentafluorobenzyl isomeric derivatives that formed. Of these R' derivatives, the N7 isomers migrated slower on silica-TLC, had higher GC retention times, had lower responses by GC-EC/MS, and were preferentially destroyed as the GC column aged. However, the N9 isomer was slower on TLC when the OH was not derivatized. This behavior was rationalized using a concept of ''polar footprint'' for the derivatives. The concept also seemed to explain the puzzling GC-EC/MS behavior of some related compounds in our laboratory. Apparently the polar footprint should be minimized in designing derivatives for trace detection by GC-EC/MS.
NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT
申请人:LCB Pharma Inc.
公开号:EP3512860B1
公开(公告)日:2020-11-25
Transition-Metal-Free N9-Amidoalkylation of Purines with N,N-Dialkylamides
作者:Dongen Lin、Saiyu Xu、Zheng Luo、Ziyang Jiang
DOI:10.1055/s-0036-1588134
日期:——
A novel method for the selective N9-amidoalkylation of purines using N,N-dialkylamides as alkylation reagents via activation of sp(3) C-H bond adjacent to an amide nitrogen atom has been developed in the presence of KI and tert-butyl hydroperoxide (TBHP). This method was simple to operate and provided series of purine derivatives in moderate to excellent yield.